Congenital myasthenic syndromes and the formation of the neuromuscular junction

Congenital myasthenic syndromes and the formation of the neuromuscular junction

Show other versions (2)

Bibliographic Details
Main Author:	Beeson, D
Format:	Conference item
Published:	2008

Similar Items

Congenital myasthenic syndromes and the neuromuscular junction.
by: Cruz, P, et al.
Published: (2014)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
by: Beeson, D, et al.
Published: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
by: Beeson, D, et al.
Published: (2008)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
by: Rodríguez Cruz, P, et al.
Published: (2018)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
by: Xufeng Liao, et al.
Published: (2023-09-01)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
by: Cossins, J, et al.
Published: (2012)

The congenital myasthenic syndromes.
by: Palace, J, et al.
Published: (2008)

Congenital myasthenic syndromes.
by: Beeson, D, et al.
Published: (1997)

Congenital myasthenic syndromes: an update.
by: Finlayson, S, et al.
Published: (2013)

Congenital myasthenic syndromes: recent advances
by: Beeson, D
Published: (2016)

Synaptic dysfunction in congenital myasthenic syndromes.
by: Beeson, D
Published: (2012)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
by: Healy, E, et al.
Published: (2014)

Therapeutic strategies for congenital myasthenic syndromes
by: Lee, M, et al.
Published: (2018)

Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes
by: Webster, R
Published: (2018)

Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
by: Vanhaesebrouck, A
Published: (2018)

Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes
by: Richard G. Webster
Published: (2018-04-01)

Congenital myasthenic syndrome caused by mutations in DPAGT.
by: Klein, A, et al.
Published: (2015)

Congenital myasthenic syndromes: Report of 7 Chile
by: Kleinsteuber, K, et al.
Published: (2003)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
by: Lashley, D, et al.
Published: (2009)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
by: Man, S, et al.
Published: (2005)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
by: Spillane, J, et al.
Published: (2012)

Congenital Myasthenic Syndrome
by: WANG Wenqing, et al.
Published: (2022-04-01)

Congenital Myasthenic Syndromes
by: J Gordon Millichap
Published: (1994-01-01)

Congenital myasthenic syndromes
by: Josef Finsterer
Published: (2019-02-01)

New diagnosis in Chilean population: congenital myasthenic syndromes
by: Kleinsteuber, K, et al.
Published: (2005)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
by: Yamanashi, Y, et al.
Published: (2008)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
by: Burke, G, et al.
Published: (2006)

The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies
by: Vanhaesebrouck, AE, et al.
Published: (2019)

Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
by: Kaela O’Connor, et al.
Published: (2023-05-01)

Congenital myasthenic syndrome with episodic apnoea: new mutations and an unusual complication
by: Davies, N, et al.
Published: (2004)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
by: Lashley, D, et al.
Published: (2010)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
by: Vincent, A, et al.
Published: (1993)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
by: Vincent, A, et al.
Published: (1993)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
by: Kinali, M, et al.
Published: (2008)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
by: Finlayson, S, et al.
Published: (2016)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
by: Mewasingh, L, et al.
Published: (2006)

Development of a dHPLC-WAVE service to detect mutations in congenital myasthenic syndrome
by: Man, S, et al.
Published: (2002)

Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
by: Konstantin A. Petrov, et al.
Published: (2018-07-01)

A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment.
by: Webster, R, et al.
Published: (2013)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
by: Bonifati, D, et al.
Published: (2004)